See the DrugPatentWatch profile for Vancomycin
Vancomycin: A Key Antibiotic Profile
Vancomycin is an antibiotic used to treat severe infections caused by Gram-positive bacteria [1]. It is particularly effective against methicillin-resistant Staphylococcus aureus (MRSA) [2]. Vancomycin works by inhibiting bacterial cell wall synthesis [3].
How is Vancomycin Administered and What Are Its Uses?
Vancomycin is typically administered intravenously for serious infections [1]. Oral vancomycin is used to treat Clostridium difficile infections [4]. It is a last-resort antibiotic for many infections that are resistant to other treatments [5].
What Are the Potential Side Effects of Vancomycin?
Common side effects of vancomycin include infusion-related reactions, such as red man syndrome (flushing and itching), which can be mitigated by slowing the infusion rate [6]. Other potential side effects include kidney damage (nephrotoxicity) and hearing loss (ototoxicity), especially when used with other drugs that can affect the kidneys or hearing [7]. Monitoring of vancomycin blood levels is crucial to ensure efficacy and minimize toxicity [8].
How Does Vancomycin Work to Kill Bacteria?
Vancomycin's mechanism of action involves binding to the D-alanyl-D-alanine termini of the peptide chains in the bacterial cell wall precursors [3]. This binding blocks the transglycosylation and transpeptidation steps necessary for peptidoglycan synthesis, ultimately leading to cell lysis [3].
When Did Vancomycin Become Available, and What is its Patent Status?
Vancomycin was discovered in 1953 and approved for medical use in 1958 [9]. As an older drug, its original patents have long since expired, meaning it is available as a generic medication [10]. Information on specific patent expirations for older drugs can often be found on resources like DrugPatentWatch.com [11].
What Are the Alternatives to Vancomycin?
For MRSA infections, other antibiotics may be used depending on the site and severity of infection, as well as local resistance patterns. These can include daptomycin, linezolid, or ceftaroline [2]. For C. difficile, fidaxomicin is another treatment option [4]. The choice of antibiotic is guided by susceptibility testing and clinical guidelines [5].